Berkshire Hathaway to sell 4.3 million VeriSign shares at $285 each

Affiliates of Berkshire Hathaway Inc. are selling 4.3 million shares of VeriSign (VRSN) at $285 per share in an underwritten secondary offering, primarily to reduce their ownership stake below the 10% regulatory threshold. VeriSign will not receive any proceeds from this sale, and Berkshire Hathaway has committed to a 365-day lock-up period for its remaining shares. This transaction follows VeriSign's recent Q2 2025 earnings report, which saw a slight EPS beat against a marginal revenue miss, with the company maintaining robust financial health and high gross profit margins.

Analysis

Berkshire Hathaway affiliates are executing a secondary offering of 4.3 million VeriSign (VRSN) shares at $285 each, a price below the stock's 52-week high of $310.60. The primary motivation for this sale is to reduce Berkshire's ownership stake below the 10% regulatory reporting threshold, rather than a signal of weakening conviction in the company's fundamentals. This interpretation is supported by a 365-day lock-up agreement on Berkshire Hathaway's remaining shares. The transaction occurs as VeriSign's stock has appreciated 64% over the past year, leading to a high P/E ratio of 36.6x and an external assessment suggesting it trades above fair value. Fundamentally, VeriSign maintains an exceptionally strong business model, evidenced by 87.9% gross profit margins and its critical role in internet infrastructure. However, its most recent Q2 2025 earnings presented a mixed picture, with a slight earnings per share beat ($2.21 vs $2.20 expected) but a marginal miss on revenue ($410M vs $410.97M anticipated), which could signal moderating top-line growth.

Key Decisions for Investors

• Investors should view Berkshire Hathaway's share sale primarily as a strategic move to manage regulatory exposure, not a bearish signal, given the 365-day lock-up on its remaining stake.
• Anticipate potential short-term price pressure as the market absorbs the secondary offering, which is priced at a discount to the recent peak.
• Given the stock's 64% annual gain and a high 36.6x P/E ratio, the recent marginal revenue miss warrants scrutiny, and investors should assess whether future growth can support the current premium valuation.